APO Research
Talk to an analyst

APO RESEARCH · REPORT

Glycogen Synthase Kinase 3 Beta

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Glycogen Synthase Kinase 3 Beta Industry Growth and Trends Forecast to 2032

19 December 202594 pages

Choose your research edition.

Industry ResearchGlycogen Synthase Kinase 3 Beta Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Glycogen Synthase Kinase 3 Beta Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Glycogen Synthase Kinase 3 Beta Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Glycogen Synthase Kinase 3 Beta Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Glycogen Synthase Kinase 3 Beta Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Glycogen Synthase Kinase 3 Beta market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Glycogen Synthase Kinase 3 Beta is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Glycogen Synthase Kinase 3 Beta is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Glycogen Synthase Kinase 3 Beta is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Glycogen Synthase Kinase 3 Beta include Neurim Pharmaceuticals Ltd, Mitsubishi Tanabe Pharma Corp, Jeil Pharmaceutical Co Ltd, DiaMedica Therapeutics Inc, Angelini Group, AMO Pharma Ltd and Actuate Therapeutics Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Glycogen Synthase Kinase 3 Beta market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Glycogen Synthase Kinase 3 Beta market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Glycogen Synthase Kinase 3 Beta market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Glycogen Synthase Kinase 3 Beta.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Glycogen Synthase Kinase 3 Beta market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Glycogen Synthase Kinase 3 Beta Market by Company

Neurim Pharmaceuticals Ltd

Mitsubishi Tanabe Pharma Corp

Jeil Pharmaceutical Co Ltd

DiaMedica Therapeutics Inc

Angelini Group

AMO Pharma Ltd

Actuate Therapeutics Inc

Glycogen Synthase Kinase 3 Beta Segment by Type

Neu-120

DM-204

AP-1

AP-001

Others

Glycogen Synthase Kinase 3 Beta Segment by Application

Dyskinesia

Musculoskeletal Disorder

Lung Cancer

Menkes Disease

Others

Glycogen Synthase Kinase 3 Beta Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glycogen Synthase Kinase 3 Beta market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Glycogen Synthase Kinase 3 Beta and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glycogen Synthase Kinase 3 Beta.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Glycogen Synthase Kinase 3 Beta manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Glycogen Synthase Kinase 3 Beta in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Neu-120 Table 2. Major Company of DM-204 Table 3. Major Company of AP-1 Table 4. Major Company of AP-001 Table 5. Major Company of Others Table 6. Global Glycogen Synthase Kinase 3 Beta Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Glycogen Synthase Kinase 3 Beta Sales by Type (2021-2026) & (K Units) Table 8. Global Glycogen Synthase Kinase 3 Beta Sales Market Share in Volume by Type (2021-2026) Table 9. Global Glycogen Synthase Kinase 3 Beta Sales by Type (2021-2026) & (US$ Million) Table 10. Global Glycogen Synthase Kinase 3 Beta Sales Market Share in Value by Type (2021-2026) Table 11. Global Glycogen Synthase Kinase 3 Beta Price by Type (2021-2026) & (US$/Unit) Table 12. Global Glycogen Synthase Kinase 3 Beta Sales by Type (2027-2032) & (K Units) Table 13. Global Glycogen Synthase Kinase 3 Beta Sales Market Share in Volume by Type (2027-2032) Table 14. Global Glycogen Synthase Kinase 3 Beta Sales by Type (2027-2032) & (US$ Million) Table 15. Global Glycogen Synthase Kinase 3 Beta Sales Market Share in Value by Type (2027-2032) Table 16. Global Glycogen Synthase Kinase 3 Beta Price by Type (2027-2032) & (US$/Unit) Table 17. North America Glycogen Synthase Kinase 3 Beta Sales by Type (2021-2026) & (K Units) Table 18. North America Glycogen Synthase Kinase 3 Beta Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Glycogen Synthase Kinase 3 Beta Sales by Type (2021-2026) & (K Units) Table 20. Europe Glycogen Synthase Kinase 3 Beta Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Glycogen Synthase Kinase 3 Beta Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific Glycogen Synthase Kinase 3 Beta Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Glycogen Synthase Kinase 3 Beta Sales by Type (2021-2026) & (K Units) Table 24. Latin America Glycogen Synthase Kinase 3 Beta Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Glycogen Synthase Kinase 3 Beta Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa Glycogen Synthase Kinase 3 Beta Sales by Type (2021-2026) & (US$ Million) Table 27. Glycogen Synthase Kinase 3 Beta Industry Trends Table 28. Glycogen Synthase Kinase 3 Beta Industry Drivers Table 29. Glycogen Synthase Kinase 3 Beta Industry Opportunities and Challenges Table 30. Glycogen Synthase Kinase 3 Beta Industry Restraints Table 31. Global Glycogen Synthase Kinase 3 Beta Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Glycogen Synthase Kinase 3 Beta Revenue Market Share by Company (2021-2026) Table 33. Global Glycogen Synthase Kinase 3 Beta Sales by Company (2021-2026) & (K Units) Table 34. Global Glycogen Synthase Kinase 3 Beta Sales Share by Company (2021-2026) Table 35. Global Glycogen Synthase Kinase 3 Beta Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Glycogen Synthase Kinase 3 Beta Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Glycogen Synthase Kinase 3 Beta Major Company Production Sites and Headquarters Table 38. Global Glycogen Synthase Kinase 3 Beta Company, Product Type & Application Table 39. Global Glycogen Synthase Kinase 3 Beta Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Glycogen Synthase Kinase 3 Beta by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Glycogen Synthase Kinase 3 Beta Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Glycogen Synthase Kinase 3 Beta Sales by Region (2021-2026) & (K Units) Table 44. Global Glycogen Synthase Kinase 3 Beta Sales Market Share in Volume by Region (2021-2026) Table 45. Global Glycogen Synthase Kinase 3 Beta Sales by Region (2021-2026) & (US$ Million) Table 46. Global Glycogen Synthase Kinase 3 Beta Sales Market Share in Value by Region (2021-2026) Table 47. Global Glycogen Synthase Kinase 3 Beta Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Glycogen Synthase Kinase 3 Beta Sales by Region (2027-2032) & (K Units) Table 49. Global Glycogen Synthase Kinase 3 Beta Sales Market Share in Volume by Region (2027-2032) Table 50. Global Glycogen Synthase Kinase 3 Beta Sales by Region (2027-2032) & (US$ Million) Table 51. Global Glycogen Synthase Kinase 3 Beta Sales Market Share in Value by Region (2027-2032) Table 52. Global Glycogen Synthase Kinase 3 Beta Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Glycogen Synthase Kinase 3 Beta Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Glycogen Synthase Kinase 3 Beta Sales by Application (2021-2026) & (K Units) Table 55. Global Glycogen Synthase Kinase 3 Beta Sales Market Share in Volume by Application (2021-2026) Table 56. Global Glycogen Synthase Kinase 3 Beta Sales by Application (2021-2026) & (US$ Million) Table 57. Global Glycogen Synthase Kinase 3 Beta Sales Market Share in Value by Application (2021-2026) Table 58. Global Glycogen Synthase Kinase 3 Beta Price by Application (2021-2026) & (US$/Unit) Table 59. Global Glycogen Synthase Kinase 3 Beta Sales by Application (2027-2032) & (K Units) Table 60. Global Glycogen Synthase Kinase 3 Beta Sales Market Share in Volume by Application (2027-2032) Table 61. Global Glycogen Synthase Kinase 3 Beta Sales by Application (2027-2032) & (US$ Million) Table 62. Global Glycogen Synthase Kinase 3 Beta Sales Market Share in Value by Application (2027-2032) Table 63. Global Glycogen Synthase Kinase 3 Beta Price by Application (2027-2032) & (US$/Unit) Table 64. North America Glycogen Synthase Kinase 3 Beta Sales by Application (2021-2026) & (K Units) Table 65. North America Glycogen Synthase Kinase 3 Beta Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Glycogen Synthase Kinase 3 Beta Sales by Application (2021-2026) & (K Units) Table 67. Europe Glycogen Synthase Kinase 3 Beta Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Glycogen Synthase Kinase 3 Beta Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific Glycogen Synthase Kinase 3 Beta Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Glycogen Synthase Kinase 3 Beta Sales by Application (2021-2026) & (K Units) Table 71. Latin America Glycogen Synthase Kinase 3 Beta Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Glycogen Synthase Kinase 3 Beta Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa Glycogen Synthase Kinase 3 Beta Sales by Application (2021-2026) & (US$ Million) Table 74. Neurim Pharmaceuticals Ltd Company Information Table 75. Neurim Pharmaceuticals Ltd Business Overview Table 76. Neurim Pharmaceuticals Ltd Glycogen Synthase Kinase 3 Beta Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Neurim Pharmaceuticals Ltd Glycogen Synthase Kinase 3 Beta Product Portfolio Table 78. Neurim Pharmaceuticals Ltd Recent Development Table 79. Mitsubishi Tanabe Pharma Corp Company Information Table 80. Mitsubishi Tanabe Pharma Corp Business Overview Table 81. Mitsubishi Tanabe Pharma Corp Glycogen Synthase Kinase 3 Beta Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Mitsubishi Tanabe Pharma Corp Glycogen Synthase Kinase 3 Beta Product Portfolio Table 83. Mitsubishi Tanabe Pharma Corp Recent Development Table 84. Jeil Pharmaceutical Co Ltd Company Information Table 85. Jeil Pharmaceutical Co Ltd Business Overview Table 86. Jeil Pharmaceutical Co Ltd Glycogen Synthase Kinase 3 Beta Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Jeil Pharmaceutical Co Ltd Glycogen Synthase Kinase 3 Beta Product Portfolio Table 88. Jeil Pharmaceutical Co Ltd Recent Development Table 89. DiaMedica Therapeutics Inc Company Information Table 90. DiaMedica Therapeutics Inc Business Overview Table 91. DiaMedica Therapeutics Inc Glycogen Synthase Kinase 3 Beta Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. DiaMedica Therapeutics Inc Glycogen Synthase Kinase 3 Beta Product Portfolio Table 93. DiaMedica Therapeutics Inc Recent Development Table 94. Angelini Group Company Information Table 95. Angelini Group Business Overview Table 96. Angelini Group Glycogen Synthase Kinase 3 Beta Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Angelini Group Glycogen Synthase Kinase 3 Beta Product Portfolio Table 98. Angelini Group Recent Development Table 99. AMO Pharma Ltd Company Information Table 100. AMO Pharma Ltd Business Overview Table 101. AMO Pharma Ltd Glycogen Synthase Kinase 3 Beta Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. AMO Pharma Ltd Glycogen Synthase Kinase 3 Beta Product Portfolio Table 103. AMO Pharma Ltd Recent Development Table 104. Actuate Therapeutics Inc Company Information Table 105. Actuate Therapeutics Inc Business Overview Table 106. Actuate Therapeutics Inc Glycogen Synthase Kinase 3 Beta Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Actuate Therapeutics Inc Glycogen Synthase Kinase 3 Beta Product Portfolio Table 108. Actuate Therapeutics Inc Recent Development Table 109. North America Glycogen Synthase Kinase 3 Beta Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 110. North America Glycogen Synthase Kinase 3 Beta Sales by Country (2021-2026) & (K Units) Table 111. North America Glycogen Synthase Kinase 3 Beta Sales Market Share by Country (2021-2026) Table 112. North America Glycogen Synthase Kinase 3 Beta Sales Forecast by Country (2027-2032) & (K Units) Table 113. North America Glycogen Synthase Kinase 3 Beta Sales Market Share Forecast by Country (2027-2032) Table 114. North America Glycogen Synthase Kinase 3 Beta Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 115. North America Glycogen Synthase Kinase 3 Beta Market Size by Country (2021-2026) & (US$ Million) Table 116. North America Glycogen Synthase Kinase 3 Beta Market Share by Country (2021-2026) Table 117. North America Glycogen Synthase Kinase 3 Beta Market Size Forecast by Country (2027-2032) & (US$ Million) Table 118. North America Glycogen Synthase Kinase 3 Beta Market Share Forecast by Country (2027-2032) Table 119. Europe Glycogen Synthase Kinase 3 Beta Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 120. Europe Glycogen Synthase Kinase 3 Beta Sales by Country (2021-2026) & (K Units) Table 121. Europe Glycogen Synthase Kinase 3 Beta Sales Market Share by Country (2021-2026) Table 122. Europe Glycogen Synthase Kinase 3 Beta Sales Forecast by Country (2027-2032) & (K Units) Table 123. Europe Glycogen Synthase Kinase 3 Beta Sales Market Share Forecast by Country (2027-2032) Table 124. Europe Glycogen Synthase Kinase 3 Beta Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 125. Europe Glycogen Synthase Kinase 3 Beta Market Size by Country (2021-2026) & (US$ Million) Table 126. Europe Glycogen Synthase Kinase 3 Beta Market Share by Country (2021-2026) Table 127. Europe Glycogen Synthase Kinase 3 Beta Market Size Forecast by Country (2027-2032) & (US$ Million) Table 128. Europe Glycogen Synthase Kinase 3 Beta Market Share Forecast by Country (2027-2032) Table 129. Asia-Pacific Glycogen Synthase Kinase 3 Beta Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 130. Asia-Pacific Glycogen Synthase Kinase 3 Beta Sales by Country (2021-2026) & (K Units) Table 131. Asia-Pacific Glycogen Synthase Kinase 3 Beta Sales Market Share by Country (2021-2026) Table 132. Asia-Pacific Glycogen Synthase Kinase 3 Beta Sales Forecast by Country (2027-2032) & (K Units) Table 133. Asia-Pacific Glycogen Synthase Kinase 3 Beta Sales Market Share Forecast by Country (2027-2032) Table 134. Asia-Pacific Glycogen Synthase Kinase 3 Beta Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 135. Asia-Pacific Glycogen Synthase Kinase 3 Beta Market Size by Country (2021-2026) & (US$ Million) Table 136. Asia-Pacific Glycogen Synthase Kinase 3 Beta Market Share by Country (2021-2026) Table 137. Asia-Pacific Glycogen Synthase Kinase 3 Beta Market Size Forecast by Country (2027-2032) & (US$ Million) Table 138. Asia-Pacific Glycogen Synthase Kinase 3 Beta Market Share Forecast by Country (2027-2032) Table 139. Latin America Glycogen Synthase Kinase 3 Beta Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 140. Latin America Glycogen Synthase Kinase 3 Beta Sales by Country (2021-2026) & (K Units) Table 141. Latin America Glycogen Synthase Kinase 3 Beta Sales Market Share by Country (2021-2026) Table 142. Latin America Glycogen Synthase Kinase 3 Beta Sales Forecast by Country (2027-2032) & (K Units) Table 143. Latin America Glycogen Synthase Kinase 3 Beta Sales Market Share Forecast by Country (2027-2032) Table 144. Latin America Glycogen Synthase Kinase 3 Beta Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 145. Latin America Glycogen Synthase Kinase 3 Beta Market Size by Country (2021-2026) & (US$ Million) Table 146. Latin America Glycogen Synthase Kinase 3 Beta Market Share by Country (2021-2026) Table 147. Latin America Glycogen Synthase Kinase 3 Beta Market Size Forecast by Country (2027-2032) & (US$ Million) Table 148. Latin America Glycogen Synthase Kinase 3 Beta Market Share Forecast by Country (2027-2032) Table 149. Middle East and Africa Glycogen Synthase Kinase 3 Beta Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 150. Middle East and Africa Glycogen Synthase Kinase 3 Beta Sales by Country (2021-2026) & (K Units) Table 151. Middle East and Africa Glycogen Synthase Kinase 3 Beta Sales Market Share by Country (2021-2026) Table 152. Middle East and Africa Glycogen Synthase Kinase 3 Beta Sales Forecast by Country (2027-2032) & (K Units) Table 153. Middle East and Africa Glycogen Synthase Kinase 3 Beta Sales Market Share Forecast by Country (2027-2032) Table 154. Middle East and Africa Glycogen Synthase Kinase 3 Beta Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 155. Middle East and Africa Glycogen Synthase Kinase 3 Beta Market Size by Country (2021-2026) & (US$ Million) Table 156. Middle East and Africa Glycogen Synthase Kinase 3 Beta Market Share by Country (2021-2026) Table 157. Middle East and Africa Glycogen Synthase Kinase 3 Beta Market Size Forecast by Country (2027-2032) & (US$ Million) Table 158. Middle East and Africa Glycogen Synthase Kinase 3 Beta Market Share Forecast by Country (2027-2032) Table 159. Key Raw Materials Table 160. Raw Materials Key Suppliers Table 161. Glycogen Synthase Kinase 3 Beta Distributors List Table 162. Glycogen Synthase Kinase 3 Beta Customers List Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources Table 166. Primary Sources List of Figures Figure 1. Glycogen Synthase Kinase 3 Beta Image Figure 2. Global Glycogen Synthase Kinase 3 Beta Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Glycogen Synthase Kinase 3 Beta Market Size (2021-2032) & (US$ Million) Figure 4. Global Glycogen Synthase Kinase 3 Beta Sales (2021-2032) & (K Units) Figure 5. Neu-120 Image Figure 6. Global Neu-120 Sales YoY Growth (2021-2032) & (K Units) Figure 7. DM-204 Image Figure 8. Global DM-204 Sales YoY Growth (2021-2032) & (K Units) Figure 9. AP-1 Image Figure 10. Global AP-1 Sales YoY Growth (2021-2032) & (K Units) Figure 11. AP-001 Image Figure 12. Global AP-001 Sales YoY Growth (2021-2032) & (K Units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global Glycogen Synthase Kinase 3 Beta Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Glycogen Synthase Kinase 3 Beta Market Share by Type 2025 VS 2032 Figure 17. North America Glycogen Synthase Kinase 3 Beta Sales Market Share in Volume by Type in 2025 Figure 18. North America Glycogen Synthase Kinase 3 Beta Sales Market Share in Value by Type in 2025 Figure 19. Europe Glycogen Synthase Kinase 3 Beta Sales Market Share in Volume by Type in 2025 Figure 20. Europe Glycogen Synthase Kinase 3 Beta Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Glycogen Synthase Kinase 3 Beta Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Glycogen Synthase Kinase 3 Beta Sales Market Share in Value by Type in 2025 Figure 23. Latin America Glycogen Synthase Kinase 3 Beta Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Glycogen Synthase Kinase 3 Beta Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Glycogen Synthase Kinase 3 Beta Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Glycogen Synthase Kinase 3 Beta Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Glycogen Synthase Kinase 3 Beta Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Dyskinesia Image Figure 30. Global Dyskinesia Sales YoY Growth (2021-2032) & (K Units) Figure 31. Musculoskeletal Disorder Image Figure 32. Global Musculoskeletal Disorder Sales YoY Growth (2021-2032) & (K Units) Figure 33. Lung Cancer Image Figure 34. Global Lung Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 35. Menkes Disease Image Figure 36. Global Menkes Disease Sales YoY Growth (2021-2032) & (K Units) Figure 37. Others Image Figure 38. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 39. Global Glycogen Synthase Kinase 3 Beta Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Glycogen Synthase Kinase 3 Beta Market Share by Application 2025 VS 2032 Figure 41. North America Glycogen Synthase Kinase 3 Beta Sales Market Share in Volume by Application in 2025 Figure 42. North America Glycogen Synthase Kinase 3 Beta Sales Market Share in Value by Application in 2025 Figure 43. Europe Glycogen Synthase Kinase 3 Beta Sales Market Share in Volume by Application in 2025 Figure 44. Europe Glycogen Synthase Kinase 3 Beta Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Glycogen Synthase Kinase 3 Beta Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Glycogen Synthase Kinase 3 Beta Sales Market Share in Value by Application in 2025 Figure 47. Latin America Glycogen Synthase Kinase 3 Beta Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Glycogen Synthase Kinase 3 Beta Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Glycogen Synthase Kinase 3 Beta Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Glycogen Synthase Kinase 3 Beta Sales Market Share in Value by Application in 2025 Figure 51. North America Glycogen Synthase Kinase 3 Beta Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. North America Glycogen Synthase Kinase 3 Beta Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Glycogen Synthase Kinase 3 Beta Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Glycogen Synthase Kinase 3 Beta Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Glycogen Synthase Kinase 3 Beta Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Europe Glycogen Synthase Kinase 3 Beta Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Glycogen Synthase Kinase 3 Beta Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Glycogen Synthase Kinase 3 Beta Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Glycogen Synthase Kinase 3 Beta Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Asia-Pacific Glycogen Synthase Kinase 3 Beta Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Glycogen Synthase Kinase 3 Beta Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Glycogen Synthase Kinase 3 Beta Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Glycogen Synthase Kinase 3 Beta Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Latin America Glycogen Synthase Kinase 3 Beta Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Glycogen Synthase Kinase 3 Beta Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Glycogen Synthase Kinase 3 Beta Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Glycogen Synthase Kinase 3 Beta Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 68. Middle East and Africa Glycogen Synthase Kinase 3 Beta Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Glycogen Synthase Kinase 3 Beta Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Glycogen Synthase Kinase 3 Beta Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Glycogen Synthase Kinase 3 Beta Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Glycogen Synthase Kinase 3 Beta Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Neu-120
  • DM-204
  • AP-1
  • AP-001
  • Others
Applications
  • Dyskinesia
  • Musculoskeletal Disorder
  • Lung Cancer
  • Menkes Disease
  • Others
Companies covered
  • Neurim Pharmaceuticals Ltd
  • Mitsubishi Tanabe Pharma Corp
  • Jeil Pharmaceutical Co Ltd
  • DiaMedica Therapeutics Inc
  • Angelini Group
  • AMO Pharma Ltd
  • Actuate Therapeutics Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Glycogen Synthase Kinase 3 Beta Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Glycogen Synthase Kinase 3 Beta Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Glycogen Synthase Kinase 3 Beta Market by Type
  6. 1.3.1 Neu-120
  7. 1.3.2 DM-204
  8. 1.3.3 AP-1
  9. 1.3.4 AP-001
  10. 1.3.5 Others
  11. 1.4 Global Glycogen Synthase Kinase 3 Beta Market Size by Type
  12. 1.4.1 Global Glycogen Synthase Kinase 3 Beta Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Glycogen Synthase Kinase 3 Beta Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Glycogen Synthase Kinase 3 Beta Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Glycogen Synthase Kinase 3 Beta Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Glycogen Synthase Kinase 3 Beta Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Glycogen Synthase Kinase 3 Beta Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Glycogen Synthase Kinase 3 Beta Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Glycogen Synthase Kinase 3 Beta Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Glycogen Synthase Kinase 3 Beta Industry Trends
  2. 2.2 Glycogen Synthase Kinase 3 Beta Industry Drivers
  3. 2.3 Glycogen Synthase Kinase 3 Beta Industry Opportunities and Challenges
  4. 2.4 Glycogen Synthase Kinase 3 Beta Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Glycogen Synthase Kinase 3 Beta Revenue (2021-2026)
  2. 3.2 Global Top Players by Glycogen Synthase Kinase 3 Beta Sales (2021-2026)
  3. 3.3 Global Top Players by Glycogen Synthase Kinase 3 Beta Price (2021-2026)
  4. 3.4 Global Glycogen Synthase Kinase 3 Beta Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Glycogen Synthase Kinase 3 Beta Major Company Production Sites & Headquarters
  6. 3.6 Global Glycogen Synthase Kinase 3 Beta Company, Product Type & Application
  7. 3.7 Global Glycogen Synthase Kinase 3 Beta Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Glycogen Synthase Kinase 3 Beta Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Glycogen Synthase Kinase 3 Beta Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Glycogen Synthase Kinase 3 Beta Tier 1, Tier 2, and Tier 3
4 Glycogen Synthase Kinase 3 Beta Regional Status and Outlook
  1. 4.1 Global Glycogen Synthase Kinase 3 Beta Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Glycogen Synthase Kinase 3 Beta Historic Market Size by Region
  3. 4.2.1 Global Glycogen Synthase Kinase 3 Beta Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Glycogen Synthase Kinase 3 Beta Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Glycogen Synthase Kinase 3 Beta Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Glycogen Synthase Kinase 3 Beta Forecasted Market Size by Region
  7. 4.3.1 Global Glycogen Synthase Kinase 3 Beta Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Glycogen Synthase Kinase 3 Beta Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Glycogen Synthase Kinase 3 Beta Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Glycogen Synthase Kinase 3 Beta by Application
  1. 5.1 Glycogen Synthase Kinase 3 Beta Market by Application
  2. 5.1.1 Dyskinesia
  3. 5.1.2 Musculoskeletal Disorder
  4. 5.1.3 Lung Cancer
  5. 5.1.4 Menkes Disease
  6. 5.1.5 Others
  7. 5.2 Global Glycogen Synthase Kinase 3 Beta Market Size by Application
  8. 5.2.1 Global Glycogen Synthase Kinase 3 Beta Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Glycogen Synthase Kinase 3 Beta Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Glycogen Synthase Kinase 3 Beta Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Glycogen Synthase Kinase 3 Beta Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Glycogen Synthase Kinase 3 Beta Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Glycogen Synthase Kinase 3 Beta Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Glycogen Synthase Kinase 3 Beta Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Glycogen Synthase Kinase 3 Beta Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Neurim Pharmaceuticals Ltd
  2. 6.1.1 Neurim Pharmaceuticals Ltd Company Information
  3. 6.1.2 Neurim Pharmaceuticals Ltd Business Overview
  4. 6.1.3 Neurim Pharmaceuticals Ltd Glycogen Synthase Kinase 3 Beta Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Neurim Pharmaceuticals Ltd Glycogen Synthase Kinase 3 Beta Product Portfolio
  6. 6.1.5 Neurim Pharmaceuticals Ltd Recent Developments
  7. 6.2 Mitsubishi Tanabe Pharma Corp
  8. 6.2.1 Mitsubishi Tanabe Pharma Corp Company Information
  9. 6.2.2 Mitsubishi Tanabe Pharma Corp Business Overview
  10. 6.2.3 Mitsubishi Tanabe Pharma Corp Glycogen Synthase Kinase 3 Beta Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Mitsubishi Tanabe Pharma Corp Glycogen Synthase Kinase 3 Beta Product Portfolio
  12. 6.2.5 Mitsubishi Tanabe Pharma Corp Recent Developments
  13. 6.3 Jeil Pharmaceutical Co Ltd
  14. 6.3.1 Jeil Pharmaceutical Co Ltd Company Information
  15. 6.3.2 Jeil Pharmaceutical Co Ltd Business Overview
  16. 6.3.3 Jeil Pharmaceutical Co Ltd Glycogen Synthase Kinase 3 Beta Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Jeil Pharmaceutical Co Ltd Glycogen Synthase Kinase 3 Beta Product Portfolio
  18. 6.3.5 Jeil Pharmaceutical Co Ltd Recent Developments
  19. 6.4 DiaMedica Therapeutics Inc
  20. 6.4.1 DiaMedica Therapeutics Inc Company Information
  21. 6.4.2 DiaMedica Therapeutics Inc Business Overview
  22. 6.4.3 DiaMedica Therapeutics Inc Glycogen Synthase Kinase 3 Beta Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 DiaMedica Therapeutics Inc Glycogen Synthase Kinase 3 Beta Product Portfolio
  24. 6.4.5 DiaMedica Therapeutics Inc Recent Developments
  25. 6.5 Angelini Group
  26. 6.5.1 Angelini Group Company Information
  27. 6.5.2 Angelini Group Business Overview
  28. 6.5.3 Angelini Group Glycogen Synthase Kinase 3 Beta Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Angelini Group Glycogen Synthase Kinase 3 Beta Product Portfolio
  30. 6.5.5 Angelini Group Recent Developments
  31. 6.6 AMO Pharma Ltd
  32. 6.6.1 AMO Pharma Ltd Company Information
  33. 6.6.2 AMO Pharma Ltd Business Overview
  34. 6.6.3 AMO Pharma Ltd Glycogen Synthase Kinase 3 Beta Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 AMO Pharma Ltd Glycogen Synthase Kinase 3 Beta Product Portfolio
  36. 6.6.5 AMO Pharma Ltd Recent Developments
  37. 6.7 Actuate Therapeutics Inc
  38. 6.7.1 Actuate Therapeutics Inc Company Information
  39. 6.7.2 Actuate Therapeutics Inc Business Overview
  40. 6.7.3 Actuate Therapeutics Inc Glycogen Synthase Kinase 3 Beta Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Actuate Therapeutics Inc Glycogen Synthase Kinase 3 Beta Product Portfolio
  42. 6.7.5 Actuate Therapeutics Inc Recent Developments
7 North America by Country
  1. 7.1 North America Glycogen Synthase Kinase 3 Beta Sales by Country
  2. 7.1.1 North America Glycogen Synthase Kinase 3 Beta Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Glycogen Synthase Kinase 3 Beta Sales by Country (2021-2026)
  4. 7.1.3 North America Glycogen Synthase Kinase 3 Beta Sales Forecast by Country (2027-2032)
  5. 7.2 North America Glycogen Synthase Kinase 3 Beta Market Size by Country
  6. 7.2.1 North America Glycogen Synthase Kinase 3 Beta Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Glycogen Synthase Kinase 3 Beta Market Size by Country (2021-2026)
  8. 7.2.3 North America Glycogen Synthase Kinase 3 Beta Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Glycogen Synthase Kinase 3 Beta Sales by Country
  2. 8.1.1 Europe Glycogen Synthase Kinase 3 Beta Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Glycogen Synthase Kinase 3 Beta Sales by Country (2021-2026)
  4. 8.1.3 Europe Glycogen Synthase Kinase 3 Beta Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Glycogen Synthase Kinase 3 Beta Market Size by Country
  6. 8.2.1 Europe Glycogen Synthase Kinase 3 Beta Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Glycogen Synthase Kinase 3 Beta Market Size by Country (2021-2026)
  8. 8.2.3 Europe Glycogen Synthase Kinase 3 Beta Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Glycogen Synthase Kinase 3 Beta Sales by Country
  2. 9.1.1 Asia-Pacific Glycogen Synthase Kinase 3 Beta Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Glycogen Synthase Kinase 3 Beta Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Glycogen Synthase Kinase 3 Beta Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Glycogen Synthase Kinase 3 Beta Market Size by Country
  6. 9.2.1 Asia-Pacific Glycogen Synthase Kinase 3 Beta Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Glycogen Synthase Kinase 3 Beta Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Glycogen Synthase Kinase 3 Beta Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Glycogen Synthase Kinase 3 Beta Sales by Country
  2. 10.1.1 South America Glycogen Synthase Kinase 3 Beta Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Glycogen Synthase Kinase 3 Beta Sales by Country (2021-2026)
  4. 10.1.3 South America Glycogen Synthase Kinase 3 Beta Sales Forecast by Country (2027-2032)
  5. 10.2 South America Glycogen Synthase Kinase 3 Beta Market Size by Country
  6. 10.2.1 South America Glycogen Synthase Kinase 3 Beta Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Glycogen Synthase Kinase 3 Beta Market Size by Country (2021-2026)
  8. 10.2.3 South America Glycogen Synthase Kinase 3 Beta Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Glycogen Synthase Kinase 3 Beta Sales by Country
  2. 11.1.1 Middle East and Africa Glycogen Synthase Kinase 3 Beta Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Glycogen Synthase Kinase 3 Beta Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Glycogen Synthase Kinase 3 Beta Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Glycogen Synthase Kinase 3 Beta Market Size by Country
  6. 11.2.1 Middle East and Africa Glycogen Synthase Kinase 3 Beta Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Glycogen Synthase Kinase 3 Beta Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Glycogen Synthase Kinase 3 Beta Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Glycogen Synthase Kinase 3 Beta Value Chain Analysis
  2. 12.1.1 Glycogen Synthase Kinase 3 Beta Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Glycogen Synthase Kinase 3 Beta Production Mode & Process
  7. 12.2 Glycogen Synthase Kinase 3 Beta Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Glycogen Synthase Kinase 3 Beta Distributors
  10. 12.2.3 Glycogen Synthase Kinase 3 Beta Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst